Fred Lorenzen

Fred Lorenzen is an accomplished finance professional currently serving as Associate Director of Financial Planning and Analysis at Merck since December 2024. Prior to this role, Fred held the position of Senior Manager of FP&A at Reaction Biology from May 2023 to December 2024. Fred's extensive experience in finance includes significant roles at TransCelerate BioPharma Inc., where responsibilities included Senior Manager of Finance and Finance Lead from June 2017 to May 2023, and at Penn Medicine, University of Pennsylvania Health System, serving as Finance Manager and Senior Financial Analyst from December 2013 to June 2017. Earlier career positions include Financial Analyst at Thomas Jefferson University and Accountant at the Icahn School of Medicine at Mount Sinai. Fred holds an MBA in Strategic Management and Analytics from Villanova University and a BS in Finance from Saint Joseph's University.